The importance of addressing the condition of nonsteroidal anti-inflammatory drug-related gastropathy.
Cryer
B
B
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects* / Q000627:therapeutic use; D001241:Aspirin / Q000009:adverse effects; D002318:Cardiovascular Diseases / Q000517:prevention & control; D017281:Cost of Illness; D016861:Cyclooxygenase Inhibitors / Q000009:adverse effects / Q000627:therapeutic use; D016481:Helicobacter Infections / Q000150:complications / Q000188:drug therapy / Q000382:microbiology; D016480:Helicobacter pylori / Q000302:isolation & purification; D006635:Histamine H2 Antagonists / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D010437:Peptic Ulcer / Q000139:chemically induced* / Q000191:economics / Q000382:microbiology*; D054328:Proton Pump Inhibitors; D014481:United States
D000894:Anti-Inflammatory Agents, Non-Steroidal; D016861:Cyclooxygenase Inhibitors; D006635:Histamine H2 Antagonists; D054328:Proton Pump Inhibitors; D001241:Aspirin